Tumor Necrosis Factor-Alpha Gene Promoter Region Polymorphism and the Risk of Coronary Heart Disease

Table 1

Baseline and clinical characteristics of the study population.

Characteristics	Controls (𝑛=310)	Patients (𝑛=310)	P value^a
Age (years)	53.2±10.46	54.3±10.15	0.164
BMI (Kg/m^2)	25.1±3.21	25.9±3.43	𝟎.𝟎𝟎𝟐^∗
Systolic BP (mmHg)	120.6±10.31	132.9±26.20	<𝟎.𝟎𝟎𝟎𝟏^∗
Diastolic BP (mmHg)	83.2±6.28	84.7±13.43	0.07
Cholesterol (TC) (mg/dL)	167.57±29.08	161.48±51.85	0.072
Triglycerides (TG) (mg/dL)	150.23±57.02	143.29±72.80	0.187
LDL-C (mg/dL)	97.41±33.21	95.96±36.11	0.603
HDL-C (mg/dL)	40.07±9.68	35.73±13.38	<𝟎.𝟎𝟎𝟎𝟏^∗

Values are given as means ± SD.
aP value calculated by Student’s t-test (unpaired).
∗P value (<0.05) indicates statistical significance.
n: number; SD: standard deviation.